Clinical Trial

Contralateral Claims Study of Clareon Vivity Pro

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
Protocol Amendment History 4 changes
critical Enrollment closed, study ongoing 2026-08-07
notable Enrollment reduced: 231 -> 165 participants 2026-08-07
critical Recruitment opened 2026-06-16
notable Trial sites expanded: 0 -> 9 locations 2026-06-16
Trial Details
NCT Number NCT07484191
Lead Sponsor Alcon Research
Conditions Aphakia, Presbyopia
Enrollment 165 participants
Start Date 2026-04-28
Primary Completion 2026-10 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-06